ANNAPOLIS, Md., March 11, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that Dr. Thomas Fuerst, Executive Vice President and Chief Scientific Officer for PharmAthene will present at the ROTH Capital Partners 23rd Annual Growth Stock Conference. The Company is scheduled to present on Monday, March 14, 2011 at 4:00 p.m. Pacific Time at the Ritz Carlton, Laguna Niguel, CA. The presentation will be webcast and can be accessed at PharmAthene's website under the Investor Relations section.SOURCE PharmAthene, Inc.
PharmAthene To Present At The ROTH Capital Partners 23rd Annual Growth Stock Conference On March 14, 2011
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.